
==== Front
BMC MicrobiolBMC MicrobiolBMC Microbiology1471-2180BioMed Central London 77410.1186/s12866-016-0774-8Research ArticleImmunoreactivity of the AAA+ chaperone ClpB from Leptospira interrogans with sera from Leptospira-infected animals Krajewska Joanna sullivancourtney@example.com Arent Zbigniew sullivancourtney@example.com Więckowski Daniel sullivancourtney@example.com Zolkiewski Michal sullivancourtney@example.com Kędzierska-Mieszkowska Sabina sullivancourtney@example.com  Department of General and Medical Biochemistry, University of Gdansk, Faculty of Biology, 80-308 Gdańsk, Poland  University Centre of Veterinary Medicine JU-UAK, University of Agriculture in Krakow, 30-059 Krakow, Poland  Departament of Biochemistry and Molecular Biophysics, Kansas State University, Manhattan, KS 66506 USA 16 7 2016 16 7 2016 2844-27-78704 2 2016 12 7 2016 © The Author(s). 2016
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.Background
Leptospira interrogans is a spirochaete responsible for leptospirosis in mammals. The molecular mechanisms of the Leptospira virulence remain mostly unknown. Recently, it has been demonstrated that L. interrogans ClpB (ClpBLi) is essential for bacterial survival under stressful conditions and also during infection. The aim of this study was to provide further insight into the role of ClpB in L. interrogans and answer the question whether ClpBLi as a potential virulence factor may be a target of the humoral immune response during leptospiral infections in mammals.

Results
ClpBLi consists of 860 amino acid residues with a predicted molecular mass of 96.3 kDa and shows multi-domain organization similar to that of the well-characterized ClpB from Escherichia coli. The amino acid sequence identity between ClpBLi and E. coli ClpB is 52 %. The coding sequence of the clpBLi gene was cloned and expressed in E. coli BL21(DE3) strain. Immunoreactivity of the recombinant ClpBLi protein was assessed with the sera collected from Leptospira-infected animals and uninfected healthy controls. Western blotting and ELISA analysis demonstrated that ClpBLi activates the host immune system, as evidenced by an increased level of antibodies against ClpBLi in the sera from infected animals, as compared to the control group. Additionally, ClpBLi was found in kidney tissues of Leptospira-infected hamsters.

Conclusions
ClpBLi is both synthesized and immunogenic during the infectious process, further supporting its involvement in the pathogenicity of Leptospira. In addition, the immunological properties of ClpBLi point to its potential value as a diagnostic antigen for the detection of leptospirosis.

Keywords
ClpBLeptospira interrogansLeptospirosisMolecular chaperonePathogenNational Science Center (Poland)Preludium Grant number 2015/17/N/NZ6/03493Krajewska Joanna issue-copyright-statement© The Author(s) 2016
==== Body
Background
Leptospira interrogans belongs to pathogenic spirochaetes causing a serious disease in both humans and animals known as leptospirosis that is considered the most widespread zoonosis of worldwide importance [1]. The vectors of this pathogen are mostly wild rodents and domestic animals, which harbor the spirochetes in the proximal renal tubules of the kidneys and chronically excrete the leptospires with urine into the environment [2]. It is worth noting that leptospirosis is also a serious economic problem, because it causes abortions, stillbirths, infertility, failure to thrive, reduced milk production, and death in domestic animals such as cows, pigs, sheep, goats, horses and dogs [3–6]. In humans the disease varies from an asymptomatic flu-like illness to an acute life-threatening infection. Despite its severity and global importance, the molecular mechanisms of leptospiral pathogenesis remain largely unknown [1]. To date, only a few proteins have been identified as potential virulence factors in Leptospira. Among them, there is the chaperone ClpB, a member the Hsp100/Clp subfamily of the AAA+ ATPases that reactivates stress-aggregated proteins in cooperation with the DnaK system [7]. Recently, ClpB from L. interrogans (ClpBLi) has been shown to be essential for bacterial survival under stressful conditions (nutrient restriction, oxidative and heat stresses) and also for the pathogen's virulence [8]. The involvement of ClpB in the response of L. interrogans to oxidative stress suggests that this chaperone may be one of key mediators of stress resistance, which is a prerequisite for Leptospira pathogenesis. The present study provides further insight into the role of ClpBLi during the infectious process. It is known that heat shock proteins (Hsps) play important roles during bacterial infections. They help pathogens to overcome stressful conditions to which they are exposed within the host cells, and represent major targets of the host's immune system. Taking into account the fact that the chaperone ClpB from some pathogenic bacteria, Francisella tularensis and Mycoplasma pneumoniae, has been shown to be immunoreactive [9, 10], we decided to investigate an immunogenic potential of ClpBLi, which could point to this chaperone's role in the pathogenicity of Leptospira and may translate into diagnostic applications.

Methods
Serum samples
We studied archived serum samples from rabbits and cattle. Rabbit antisera (n = 8) against L. interrogans serovars: Icterohaemorrhagiae, Hardjo, and Canicola, and L. borgpetersenii serovars: Hardjo, Javanica, were prepared as described by [11]. Polyclonal rabbit antiserum prepared against the L. interrogans ClpB (residues 158–334; anti-ClpBLi158–334 serum) [8] and provided by M. Picardeau was used as a positive control and the pre-immune serum was used as a negative control. Bovine sera were collected from cattle (n = 10) experimentally infected with L. borgpetersenii serovar Hardjo via conjunctival instillation of 1 x 106 bacteria. Blood samples were collected 28 days after the challenge and in one case 210 days after the challenge (this serum was used as a positive control showing the highest OD in ELISA). Sera from uninfected cattle (n = 8) and also a fetal bovine serum were used as negative controls. To confirm the serological status of leptospiral infection, the sera were subjected to the microscopic agglutination test (MAT) [11, 12] and used at dilutions 1:100 for Western blotting or 1:200 for ELISA.

Kidney homogenate preparation
For detection of ClpBLi in kidney tissues from Leptospira-infected hamsters, the kidneys were macerated with nine parts of a 1 % BSA diluent and inoculated into Tween80/40/ LH semi-solid medium. Cultures were incubated at 28–30 °C, for up to 10 weeks and examined weekly by dark-field microscopy to detect the growth of leptospires. The same macerated kidney tissues (20 μg sample of homogenate) were used for Western-blotting analysis. Total protein concentration in the homogenates was determined by the method of Bradford [13].

Plasmid construction for protein overproduction
L. interrogans clpB gene (2583 bp) was amplified from genomic DNA of L. interrogans by PCR using AccuTaq LA polymerase MIX (Sigma) with the following primers: CATATGAAATTAGATAAACTTACATCCAAATT with the NdeI restriction site underlined, and AAGCTTTTAAACTACAACAACTACC with the HindIII restriction site underlined. DNA primers were synthesized by Genomed S.A. (Warsaw, Poland). First, the PCR product was cloned into pJET1.2 blunt vector (Fermentas), then digested with NdeI, HindIII, and ligated with the linearized pET NdeI-HindIII vector. The sequence of the resulting construct was confirmed by DNA sequencing (Genomed S.A.). Leptospira genomic DNA was extracted with a QIAamp DNA Mini Kit (Qiagen).

DNA plasmid preparation and transformation of E. coli cells were done according to [14].

Purification of the recombinant ClpBL
L. interrogans ClpB protein was overproduced in E. coli BL21(DE3) strain (Novagen) and purified according to the procedure similar to that used to obtain ClpB from Ehrlichia chaffeensis [15]. Briefly, bacteria were grown at 37 °C to OD600 = 0.6 and then induced with 0.5 mM IPTG for 2 h. Next, the cells were collected and suspended in 50 mM Tris–HCl (pH 7.4), 300 mM NaCl, 20 mM imidazole and 0.1 % Triton X-100, then disrupted by sonication in the presence of the protease inhibitor PMSF and centrifuged to collect the soluble extract. Next, polyethyleneimine (PEI) was added to precipitate nucleic acids. After centrifugation (20 000 g, 1 h), the supernatant was applied to a Ni-NTA column (Qiagen) and the bound protein was eluted with 50 mM Tris–HCl (pH 7.4), 300 mM NaCl, and 0.1 % Triton X-100 and 250 mM imidazole. Fractions containing a 6His-tagged ClpBLi (a calculated molecular mass of 98 488.59 Da) were identified with SDS-PAGE electrophoresis and Coomassie blue staining, then combined and further purified by gel filtration on Superdex 200 (Sigma) equilibrated with 50 mM Tris–HCl (pH 7.5), 10 % glycerol, 1 mM EDTA and 1 mM DTT. The pooled fractions containing ClpBLi were dialyzed against dialysis buffer (50 mM Tris–HCl pH 7.5, 1 mM EDTA, 1 mM DTT, 20 mM MgCl2, 200 mM KCl, 10 % glycerol) and stored at −70 °C. The N-terminal histidine tag was removed by proteolytic digestion using the Thrombin Cleavage Capture Kit (Novagen) according to the manufacturer's protocol. The identity of the purified ClpBLi was confirmed by a liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis of tryptic peptides obtained after trypsin cleavage of the protein, performed at the MS LAB IBB PAN (Warsaw, Poland). The equipment used was sponsored in part by the Centre for Preclinical Research and Technology (CePT), a project co-sponsored by European Regional Development Fund and Innovative Economy, The National Cohesion Strategy of Poland.

SDS-PAGE and Western blotting analysis
To assess immune reactivity of ClpBLi, SDS-PAGE electrophoresis was performed according to [16] using 10 % polyacrylamide gels and Western blotting was performed as described [17]. The blots were blocked with 0.1 % Tween 20 in Tris-buffered saline (TBS) for 1 h at room temperature and then incubated overnight at 4 °C with anti-ClpBLi158–334 serum (1: 2000 dilution) [8] or polyclonal rabbit and bovine sera (1:100 dilution) against Leptospira strains. After primary antibody incubation, the blots were washed three times with TBS containing 0.05 % Tween 20 and incubated for 1 h at room temperature with the goat anti-rabbit IgG horseradish peroxidase (HRP) conjugate (Sigma) diluted 1: 3000 or the polyclonal rabbit anti-cow Ig/HRP conjugate (DakoCytomation) diluted 1: 1000. The blots were then washed three times as described above and were developed using 3,3′-diaminobenzidine (Sigma), and H2O2 as substrates.

ELISA procedure
ELISA (enzyme-linked immunosorbent assay), was performed to analyze the immune response in animals experimentally exposed to L. interrogans serovars. Costar 96 well EIA/RIA polystyrene high-binding plates were coated with 100 μl of 0.625 μg/ml of the recombinant ClpBLi (a capture antigen) resuspended in phosphate-buffered saline (PBS) by incubation overnight at 4 °C. The plates were then washed five times with PBST buffer (PBS containing 0.05 % Tween 20) and non-specific binding sites were blocked by incubation with 100 μl of 0.1 % Tween 20 in PBS buffer for 1 h at room temperature. The wells were washed five times with PBST buffer. Control and duplicate animal serum samples were diluted 200-fold in PBST buffer and 50 μl of the diluted sera (in duplicate) were applied to each well and incubated at 37 ° C for 1 h, followed by five rinses with PBST buffer. Next, secondary HRP-conjugated anti-rabbit (Abcam) (diluted 1:10 000) or anti-cow IgG (DakoCytomation) (diluted 1:2000) were added to each well and incubated for 1 h at 37 °C. The plates were then washed five times with PBS buffer and 3,3′,5,5′-tetramethylbenzidine (TMB) (Sigma-Aldrich) was added to detect the antibodies. The reaction was stopped after 10 min by the addition of 50 μl of 1 M H2SO4. The absorbance at 450 nm was measured using PerkinElmer Multimode Plate Reader (Enspire). The assay was performed three times for each serum.

Data analysis
The statistical significance of differences between the ELISA results obtained for sera collected from uninfected and infected animals were determined using the Welch's adjusted one-way ANOVA followed by the post-hoc Scheffe multiple comparison test. P < 0.05 was considered statistically significant. Results of data analysis are presented in the graphs as the median values. All statistical analyses were performed using STATISTICA PL program.

Results
Analysis of the amino-acid sequence of the molecular chaperone ClpB from L. interrogans
The clpBLi gene encodes a protein of 860 amino acid residues with a predicted molecular mass of 96325.2 Da. Sequence alignment of ClpBLi (Fig. 1) revealed that this protein shows a multi-domain organization similar to that of the well-characterized ClpB from Escherichia coli (ClpBEc). Thus, ClpBLi contains an N-terminal domain (ND1-145aa), two nucleotide binding domains (NBD1161-342aa, NBD2560-768aa) and a middle coiled-coil domain (MD393-527aa) (Fig. 1). Both NBDs, involved in ATP binding and ATP hydrolysis, contain all characteristic and conserved sequence mofits of AAA+ ATPases (ATPases associated with a variety of cellular activities), i.e. Walker A (GX4GKT/S), Walker B (Hy2DE) and sensor 1/2 motifs. Conserved arginine residues called Arg fingers are also present in both NBD domains. Sequence alignment of the ClpB sequences from bacteria L. interrogans and E. coli using the Clustal software revealed that the total sequence identity between them is only 52 %; 27.7 % within ND, 45.3 % within MD, 72 % within NBD1, and 65.7 % within NBD2. Therefore, the most highly conserved are the NBD domains and the main differences between L. interrogans and E. coli ClpB are in the N-terminal domain and the coiled-coil middle domain.Fig. 1 Proposed domain organization of ClpB from L. interrogans.
a The diagram shows structural domains of the protein: N-terminal domain (ND) with the double Clp_N motif, nucleotide binding domain 1 (NBD1), middle coiled-coil domain (MD) and nucleotide binding domain 2 (NBD2). Conserved ATPase motifs such as the Walker A (A), Walker B (B), sensor 1, sensor 2 (GAR) and the Arg fingers (R), coordinating ATP binding and hydrolysis are also indicated. Conserved residues of these motifs are marked in bold. b Sequence alignment of ClpB from E. coli (BEc) and L. interrogans (BLi). Domain boundaries are indicated below the amino acid sequence. The conserved motifs are shown in red. Identical and similar amino acid resides are shaded in black and gray, ... respectively



Expression of the clpBLi gene in E. coli cells and purification of ClpBLi
To examine whether ClpBLi shows an immunogenic potential, which could point to its participation in the pathogenicity of Leptospira, we obtained a construct expressing clpBLi (pET28clpBLi) and then overproduced the recombinant ClpBLi as a 6-histidine-tagged protein in E. coli B21(DE3) cells. As expected, the expression of pET28clpBLi resulted in the ~100-kDa protein, corresponding to ClpBLi that was soluble in E. coli cells. The protein was purified from the soluble fraction using two separation techniques: immobilized metal affinity chromatography (IMAC) and gel filtration chromatography (Fig. 2a). The identity of ClpBLi was confirmed with an LC-MS/MS analysis (Fig. 3). The obtained peptide map covered 88 % of the amino acid sequence of ClpBLi. In addition, LC-MS/MS data indicated that the purified ClpBLi was not contaminated with ClpB from the E. coli host strain. The purified ClpBLi was subsequently digested with thrombin to remove the N-terminal 6His-tag (Fig. 2b). The post-cleavage N-terminal sequence of the recombinant ClpBLi protein contains three additional amino acid residues, namely GlySerHis, and in such form the protein was further characterized by Western blotting analysis and ELISA assay.Fig. 2 Purification of L. interrogans ClpB. a The Coomassie blue-stained SDS-PAGE gel showing the lysates from E. coli cells transformed with the recombinant plasmid expressing clpB
Li (pET28clpB
Li) without induction (−) (lane 1) and induced with IPTG (+) (lane 2), and the representative fractions obtained following the nickel resin (Ni-NTA, lane 3) and gel filtration (GF, lane 4) purification of ClpBLi. The arrow indicates the position of the 6His-tagged ClpBLi (~98.5 kDa). b The Coomassie blue-stained SDS-PAGE gel showing ClpBLi digested with thrombin (lane 1) and the 6His-tagged ClpBLi (lane 2). The positions of protein size markers (M) (in kDa), PageRuler prestained Protein Ladder (Thermo Scientific), are shown on the ... left

Fig. 3 LC-MS/MS analysis of the purified ClpBLi. The amino acid sequence of ClpBLi is shown with the peptides detected by LC-MS/MS indicated in ... red



Immunogenic capacity of ClpBLi
The immune reactivity of ClpBLi with serologically positive sera from rabbits and cattle experimentally infected with two pathogenic Leptospira species (L. interrogans and L. borgpetersenii) was tested by Western blotting (Figs. 4a and 5a) and ELISA assay (Figs. 4b and 5b) and compared to the sera from uninfected healthy controls. We found that all the tested sera prepared from Leptospira-infected animals, but not from the uninfected controls, strongly reacted with ClpBLi in Western blotting (Figs. 4a, 5a). The ELISA signals of the sera from infected animals were also significantly higher than those of uninfected animals (Figs. 4b, 5b; P < 0.001). These results show that Leptospira infection induces production of anti-ClpBLi antibodies in animal models. The cross-reactivity between L. interrogans and L. borgpetersenii is not surprising due to ~95 % sequence similarity between ClpB from those two species [8].Fig. 4 Immune reactivity of the recombinant ClpBLi with rabbit sera. a The purified ClpBLi protein (250 ng) was resolved by SDS-PAGE and analyzed by Western blotting using: the antiserum against ClpBLi158–334 (a positive control), pre-immune control serum (a negative control), or polyclonal rabbit antisera raised against: L. interrogans and L. borgpetersenii serovars as indicated in the figure. The positions of protein size markers (M) (in kDa), PageRuler prestained Protein Ladder (Thermo Scientific), are shown on the left. The arrow indicates the position of ClpBLi. (b) ELISA analysis of the recombinant ClpBLi protein as a capture antigen using all the above rabbit sera. The data were analyzed using Welch adjusted one-way ANOVA. Symbols: (▫), the median value; (box), 25 %–75 % range around the median value; (whiskers), min-max range. (***) denotes P < 0.001; ns, not statistically significant

Fig. 5 Immune reactivity of the recombinant ClpBLi with bovine sera. a The purified ClpBLi protein (250 ng) was resolved by SDS-PAGE and analyzed by Western blotting using the antiserum against ClpBLi158–334 (a positive control; control +), polyclonal bovine antisera raised against: L. borgpetersenii serovar Hardjo (Leptospira-infected cattle), and sera collected from uninfected cattle (healthy group; negative control). The positions of protein size markers (M) (in kDa), PageRuler prestained Protein (Thermo Scientific), are shown on the left. The arrow indicates the position of ClpBLi (~100-kDa). b ELISA analysis of the recombinant ClpBLi protein as a capture antigen using the above bovine sera. Fetal bovine serum was also used. The data were analyzed using Welch adjusted one-way ANOVA. Symbols: (▫), the median value; (box), 25 %–75 % range around the median value, (whiskers), min-max range. (***) denotes P <... 0.001



Detection of ClpBLi in Leptospira-infected animals
Additionally, we detected ClpBLi (96-kDa protein) in the infected hamster kidney tissue (Fig. 6), from which leptospires were isolated using standard culture method. No reactivity of the 96-kDa protein with anti-ClpBLi158–334 serum was observed in the kidney homogenate obtained from an uninfected hamster (Fig. 6, lane 4). The result indicates that ClpBLi, is produced during an experimental infection of animals.Fig. 6 Detection of ClpBLi in hamster kidney tissues. The macerated kidney tissues containing ~20 μg proteins were subjected to SDS-PAGE followed by Western blotting with anti-ClpBLi158–334 serum. Lane 1, purified ClpBLi (a positive control); lanes 2, 3, 5, 6, the kidney homogenates from hamsters infected with L. interrogans serovar Hardjo and euthanized 14 (lane 2) or 6 (lanes: 3,5,6) weeks post infection; lane 4, the kidney homogenate from an uninfected hamster. The arrow indicates the position of the 6His-tagged ClpBLi (~98.5 kDa). The position of 100-kDa protein marker (PageRuler unstained Protein Ladder; Thermo Scientific), is shown on the ... left



In summary, our data indicate that the molecular chaperone ClpBLi is immunogenic and detectable in animals infected with pathogenic Leptospira spp.

Discussion
Leptospires like many other pathogenic bacteria are exposed to a significant stress during infection of host cells, frequently resulting in protein misfolding and aggregation. Despite being exposed to stressful conditions, pathogens survive, overcome host defense mechanisms, and cause the disease symptoms. The specific mechanisms of the host invasion by leptospires are not well defined. In particular, the molecular basis for virulence remains unknown, due to the lack of genetic tools for the manipulation of Leptospira. The fact that ClpB is usually up-regulated in pathogenic microorganisms [8, 15] suggests that the disaggregase activity of ClpB may be essential for their virulence. Moreover, the involvement of ClpB in the response of L. interrogans to oxidative stress [8] suggests that this chaperone may be one of key mediators of stress resistance, which is a prerequisite for Leptospira pathogenesis. The chaperone ClpB may function either as a true virulence factor directly involved in causing the disease or a virulence-associated protein that can be essential for colonization of the host. Virulence gene products are often immunogenic and responsible for acquired immunity that protects against disease [18]. At this point it should be also noted that molecular chaperones despite their cytosolic localization are strongly immunogenic in a number of bacterial infections [19]. It has been reported that some chaperones (e.g. GroEL) may be associated with the outer membrane of the pathogenic bacteria or exported from the bacterial cell after heat shock [19]. Therefore, exposure of bacterial Hsps to the host's immune system is possible during infection. Indeed, ClpB from some pathogens (i.e. Mycoplasma pneumoniae, Francisella tularensis) is an immunoreactive protein [9, 10]. The total sequence identity between ClpB proteins from these pathogens is only ~40 %. It is likely that ClpB as an important mediator of resistance to oxidative stress could be also a potential target for the host immune response during leptospiral infections in mammals. Therefore, we decided to investigate an immunogenic potential of this chaperone in Leptospira. The use of the E. coli expression system allowed us to produce the recombinant ClpBLi protein and to assess its immune reactivity with sera collected from Leptospira-infected animals and the uninfected healthy controls. Our results show that ClpB is immunogenic during leptospiral infections because it was recognized by sera collected from experimentally infected animals (see Figs. 4 and 5). Thus, among the antibodies raised against leptospiral proteins, there were specific antibodies against ClpBLi. This is the first study where ClpB from pathogenic Leptospira species was evaluated for its ability to elicit immune responses in animals. Moreover, our results suggest that ClpBLi could be considered as a potential antigen candidate for a diagnostic test. We postulate that the presence of species-specific domains (e.g. ND or MD, see Fig. 1) in the antigen could minimize a cross-reactivity of antibodies with ClpB from different bacteria. Further prospective studies are needed to assess the ClpBLi's predictive value in leptospirosis diagnostics. In addition, the presence of ClpBLi in the infected hamster kidney tissues (see Fig. 6) demonstrates that the chaperone is produced by pathogen during infection of the host further confirming the involvement of ClpB in the pathogenicity of Leptospira.

Conclusions
Identification of Leptospira virulence factors and understanding their properties is crucial for uncovering the diseases mechanisms. This study underlines the potential importance of the chaperone ClpB in leptospiral infections. We believe that our data provide new information, which may lead to a better understanding of the role of ClpB and possibly other stress-response factors in the life cycle of the pathogenic bacterium L. interrogans. It is worth noting that since ClpB does not exist in animal cells, it might become a promising target for novel therapies against pathogenic Leptospira species. Further studies are needed to determine the biological role of ClpB during leptospiral infection in mammals and its diagnostic or even immunoprotective potential. The recombinant ClpBLi produced in this work will help in further biochemical characterization of this chaperone and the analysis of its function in the pathogen.

Acknowledgements
We thank M. Picardeau (Institut Pasteur, Unité de Biologie des Spirochètes) for the generous gift of ClpBLi antiserum. We are very grateful to S. Barańska (University of Gdańsk) for her excellent assistance in the statistical analyses.

Funding
This work was supported by the Preludium Grant number 2015/17/N/NZ6/03493 (to JK) from the National Science Center (Poland).

Availability of supporting data
The DNA sequence of L. interrogans clpB gene was retrieved from the EMBL-EBI (accession number AAS70592.1) website (http://www.ebi.ac.uk/ena/data/view/AAS70592). The protein sequences of L. interrogans and E. coli ClpB were retrieved from UniProtKB (accession number Q72QU2 (CLPB_LEPIC)/http://www.uniprot.org/uniprot/Q72QU2 and P63284 (CLPB_ECOLI)/ http:// www.uniprot.org/uniprot/P63284).

Authors' contributions
JK, ZA, DW performed the experiments. SKM designed the experiments, analyzed the data and drafted the manuscript. MZ assisted in data analyses and the preparation of manuscript. All authors read and approved the final manuscript.

Competing interests
The authors declare that they have no competing interests.

Consent for publication
Not applicable.

Ethics approval and consent to participate
The sera and kidney tissues used in this work were originally collected during another study (project license number PPL2608, date of approval 15 October 2008). All operators involved in the study, protocols, and premises were licensed under the Animals (Scientific Procedures) Act (1986) (ASPA).
==== Refs
References
1. Adler B  Lo M  Seemann T  Murray GL   Pathogenesis of leptospirosis: the influence of genomics Vet Mirobiol 2011 153 3 81 
2. Cino M   New insights into the pathogenicity of leptospires: evasion of host defences New Microbiol 2010 33 283 292 21213586 
3. Ryan EG  Nola L  O'Grady L  More SJ  Doherty ML   Seroprevalence of Leptospira  Hardjo in the irish suckler cattle population Ir Vet J 2012 65 8 10.1186/2046-0481-65-8 22546216 
4. Arent Z  Kędzierska-Mieszkowska S   Seroprevalence study of leptospirosis in horses in northern Poland Vet Rec 2013 172 844-27-7870/vr.101239 23362180 
5. Arent Z  Frizzell C  Gilmore C  Mackie D  Ellis WA   Isolation of leptospires from genital tract of sheep Vet Rec 2013 173 844-27-7870/vr.101969 24277917 
6. Arent ZJ  Andrews S  Adamama-Moraitou K  Gilmore C  Pardali D  Ellis WA   Emergence of novel Leptospira  serovars: a need for adjusting vaccination policies for dogs? Epidemiol Infect 2013 141 1148 1844-27-7870/S0950268812002087 22998981 
7. Zolkiewski M   ClpB cooperates with DnaK, DnaJ, and GrpE in suppressing protein aggregation J Biol Chem 1999 274 28083 28844-27-7870/jbc.844-27-78703 10497158 
8. Lourdault K  Cerqueira GM  Jr Wunder EA  Picardeau M   Inactivation of clpB  in the pathogen Leptospira interrogans  reduces virulence and resistance to stress conditions Infect Immun 2844-27-7870 3844-27-7870/IAI.05844-27-78700091 
9. Havlasova J  Hemychowa L  Brechta M  Hubalek M  Lenco J  Larsson P    Proteomic analysis of anti-Francisella  tularensis LVS antibody response in murine model of tularemia Proteomics 2005 5 2090 2844-27-7870/pmic.200401123 15892173 
10. Kannan TR  Musatovova O  Gowda P  Baseman JB   Characterization of a unique ClpB protein of Mycoplasma pneumoniae  and its impact on growth Infect Immun 2844-27-7870 5844-27-7870/IAI.00844-27-78709336 
11. WHO  Human Leptospirosis: Guidance for Diagnosis Surveillance and Control 2003 
12. Wolff JW. The laboratory diagnosis of leptospirosis. Publ. No. 183, American Lecture Series. Charles C. Thomas, Publisher, Springfield, Illinois, USA; 1954
13. Bradford MM   A rapid and sensitive method for quantition of proteins utilizing the principles of protein-dye binding Anal Biochem 1976 72 248 844-27-7870/0003-2697(76)90527-3 942051 
14. Sambrook J  Fritsch EF  Maniatis T   Molecular cloning: a laboratory manual 1989 New York Cold Spring Harbor Laboratory Press 
15. Zhang T  Kedzierska-Mieszkowska S  Liu H  Cheng C  Ganta RR  Zolkiewski M   Aggregate-reactivation activity of the molecular chaperone ClpB from Ehrlichia chaffeensis  PLoS One 2013 
16. Laemmli UK   Cleavage of the structural protein during assembly of the head of bacteriophage T4 Nature 1970 227 680 844-27-7870/227680a0 5432063 
17. Harlow E  Lane D   Antibodies. A laboratory manual, CSH 1988 New York Cold Spring Harbor 
18. Ferreria HB  de Castro LA   A preliminary survey of M. hyopneumoniae  virulence factors based on comparative genomic analysis Genet Mol Biol 2007 30 245 844-27-7870/S1415-47572007000200012 
19. Amemiya K  Meyers JL  DeShazer D  Riggins RN  Halasohoris S    Detection of the host immune response to Burkholderia mallei  heat-shock proteins GroEL and DnaK in a glanders patient and infected mice Diagn Microbiol Infect Dis 2007 59 137 844-27-7870/j.diagmicrobio.2007.04.017 17908615


{'source': 'PubMedDataset'}